Natera, Inc.
NTRACIK 0001604821 · Services-Medical Laboratories · Nasdaq
- Natera, Inc. (until 2026-06-16)
Revenue (TTM)
$2.34B
+35.9% YoY
Q1 May 2026
Net Income (TTM)
−$340.51M
−9.3% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.48
+0.7% YoY
Q1 May 2026
Gross Margin
1.7%
Q1 May 2026
Operating Margin
-16.3%
Q1 May 2026
Net Margin
-14.6%
Q1 May 2026
Free Cash Flow (TTM)
−$45.13M
Q1 May 2026
Cash
$466.01M
Q1 May 2026
Total Debt
$363.25M
Q1 May 2026
Shares Outstanding
143.22M sh
Q1 May 2026